CR
Compliant RX Inc.
SEC filingOther Technology · Coral Springs, FL
Amount raised$1000Ksold at filing
Total offering$3M$2M still open
Investors in the raise1count reported to the SEC
FiledMar 5, 2026first sale Feb 6, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Adam NadlerExecutive Officer, Director
Michael DowdleDirector
Adam HandfingerExecutive Officer, Director
Rhiannon SullivanExecutive Officer
Executive officers, directors and promoters as listed on the Form D.